| Jessica Sareussen, | |
|
1101 Sunset Blvd Ste B, Kenner, LA 70065-6810 | |
| (850) 588-9641 | |
| (888) 711-0441 |
| Full Name | Jessica Sareussen |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 3 Years |
| Location | 1101 Sunset Blvd Ste B, Kenner, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609541952 | NPI | - | NPPES |
| 327805 | Other | LA | OCCUPATIONAL THERAPY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 327805 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fox Rehabilitation Services La Llc | 7214309079 | 14 |
News Archive
St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer.
A medicine to treat children's leukemia is in such short supply that hospitals may run out within weeks; meanwhile, families of people with Alzheimer's disease are clamoring to use a skin-cancer drug after a promising study in mice.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.
Some people may have trouble losing weight, while others find it hard to gain weight. Now, a team of scientists may have found the answer to why some people remain thin despite eating without restriction.
› Verified 5 days ago
| Provider Name | Senior Therapy Solutions |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1932739984 PECOS PAC ID: 8527307313 Enrollment ID: O20200504000898 |
News Archive
St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer.
A medicine to treat children's leukemia is in such short supply that hospitals may run out within weeks; meanwhile, families of people with Alzheimer's disease are clamoring to use a skin-cancer drug after a promising study in mice.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.
Some people may have trouble losing weight, while others find it hard to gain weight. Now, a team of scientists may have found the answer to why some people remain thin despite eating without restriction.
› Verified 5 days ago
| Provider Name | Fox Rehabilitation Services La Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952027906 PECOS PAC ID: 7214309079 Enrollment ID: O20230206000420 |
News Archive
St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer.
A medicine to treat children's leukemia is in such short supply that hospitals may run out within weeks; meanwhile, families of people with Alzheimer's disease are clamoring to use a skin-cancer drug after a promising study in mice.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.
Some people may have trouble losing weight, while others find it hard to gain weight. Now, a team of scientists may have found the answer to why some people remain thin despite eating without restriction.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Sareussen, Po Box 168, Crystal Springs, MS 39059-0168 Ph: (850) 588-9641 | Jessica Sareussen, 1101 Sunset Blvd Ste B, Kenner, LA 70065-6810 Ph: (850) 588-9641 |
News Archive
St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer.
A medicine to treat children's leukemia is in such short supply that hospitals may run out within weeks; meanwhile, families of people with Alzheimer's disease are clamoring to use a skin-cancer drug after a promising study in mice.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.
Some people may have trouble losing weight, while others find it hard to gain weight. Now, a team of scientists may have found the answer to why some people remain thin despite eating without restriction.
› Verified 5 days ago
Vicki Ross Jensen, LOTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 Everglades St, Kenner, LA 70065 Phone: 504-466-1090 | |
Torrey Dickson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 56 Lisa Ave, Kenner, LA 70065 Phone: 504-982-7123 | |
Brittany Salemi Gurley, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3510 E Louisiana State Dr, Kenner, LA 70065 Phone: 504-465-9922 | |
Elizabeth Russell Collins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8713 Sally Ct, Kenner, LA 70062 Phone: 317-379-2524 |